Global Genome Editing Market Forecast to 2025

  • Product Code:
  • Published Date:
    Mar 2019
  • Region:
  • Pages:
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Infoholic Research
Global Genome Editing Market - Drivers, Restraints, Opportunities, Trends, and Forecast, 2019–2025
[98 pages report] This market research report includes a detailed segmentation of the global genome editing market – by technology (CRISPR, TALEN, ZFN, and Others), by application (Cell Line Engineering, Genetic Engineering, and Others), By end-user (Research Institutes, Biotechnology and Pharmaceutical Companies, and Contract Research Organizations), by regions (North America, Europe, Asia Pacific, and Rest of the World).
Overview of the Global Genome Editing Market
Infoholic’s market research report predicts that the “Global Genome Editing Market” will grow at a CAGR of 14.4% during the forecast period. The market has witnessed steady growth in the past few years with the development in technology and the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled due to increase in genetic disorders, increasing investment and funds, and technological advancements in genome editing.

The market continues to grow and is one of the increasingly accepted market in many countries worldwide. Vendors are focusing towards obtaining funds and collaborating with universities to enlarge their research and development capabilities. The majority of the revenue is generated from the leading players in the market with dominating sales of ThermoFisher Scientific, GenScript Corp., Sangamo Therapeutics, Lonza Group, and Horizon Discovery Group plc.
According to Infoholic Research analysis, North America accounted for the largest share of the global genome editing market in 2018. US dominates the market with majority of genome editing companies being located in this region. However, China has not been too far behind and has great government support for the research in genome editing field.
By Technology:
• Others
In 2018, the CRISPR segment occupied the largest share due to specific, effective, and cost-effective nature of the technology. Many companies are focusing on providing genome editing services. For instance, in January 2019, Horizon Discovery extended CRISPR screening service to primary human T cells.
By Applications:
• Cell Line Engineering
• Genetic Engineering
• Others
In 2018, the cell line engineering accounted the maximum share followed by genetic engineering. Increase in the number of people suffering with genetic disorders has driven the growth of the genome editing market.
By End Users:
• Research Institutes
• Biotechnology and Pharmaceutical Companies
• Contract Research Organizations
In 2018, the biotechnology and pharmaceutical companies gained the highest market share for genome editing market due to increased pervasiveness of cancer and infectious diseases are driving research goings-on in biotechnology & pharmaceutical companies segment.
By Regions:
• North America
• Europe
The market is dominated by North America, followed by Asia Pacific and Europe. The major share of the North America market is from the US due to quick adoption of new and advanced technologies.
Genome Editing Market Research Competitive Analysis – The market is extremely fragmented with several smaller companies struggling for market share. Big pharmaceutical establishments have also united with venture capitalists to provide funding to the start-ups. In 2015, Bayer financed $335 million and in the very same year, Celgene combined with Abingworth invested $64 million in CRISPR Therapeutics. The NIH recently granted 21 somatic cell genome editing grants of almost $86 million over the next half a decade. These endowments are the foremost to be granted through the Somatic Cell Genome Editing (SCGE) program that was initiated in January 2018 with NIH Common Fund.
The companies are collaborating and licensing to increase their capabilities in the market. CRISPR, TALEN, ZFN, Meganuclease, ARCUS, and RTDS are some of the key technology areas concentrated by key players in the market. Since 2015, the deals on the CRISPR technology has drastically increased.
Key vendors:
• ThermoFisher Scientific
• GenScript Corp.
• Sangamo Therapeutics
• Lonza Group
• Horizon Discovery Group plc
• Merck KGaA
• Transposagen Biopharmaceutical
• CRISPR Therapeutics
• Editas Medicine
• Integrated DNA Technologies
• New England Biolabs
• Origene Technologies, Inc.
Key competitive facts –
• Genetic editing technologies are intensely evolving from previous two decades and has facilitated in the variation of genome further rapidly and in a less expensive technique.
• The US is the leader in the CRISPR technology, while the market for TALEN genome editing technology is dominated by China.
Benefits – The report provides complete details about the usage and adoption rate of genome editing market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the healthcare segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Key Takeaways:
• Understanding the potential market opportunity with precise market size and forecast data
• Detailed market analysis focusing on the growth of genome editing industry
• Factors influencing the growth of genome editing market
• In-depth competitive analysis of dominant and pureplay vendors
• Prediction analysis of genome editing market in both developed and developing regions
• Key insights related to major segments of the genome editing market
• Latest market trend analysis impacting the buying behavior of the consumers

Key Stakeholders –

Table of Contents
1 Industry Outlook 9
1.1 Industry Overview 9
1.2 Total Addressable Market 9
1.2.1 Industry Trends 10
2 Report Outline 11
2.1 Report Scope 11
2.2 Report Summary 11
2.3 Research Methodology 13
2.4 Report Assumptions 13
3 Market Snapshot 14
3.1 Market Definition – Infoholic Research 14
3.2 Segmented Addressable Market (SAM) 14
3.3 Industry Trends 15
3.4 Related Markets 16
3.4.1 Genetic Testing 16 Trends of the genetic testing market 16
3.4.2 Liquid Biopsy Market 16 Trends of Liquid biopsy market 17
3.4.3 Next-generation sequencing 18 Trends in the Next-generation sequencing market 18
4 Market Outlook 19
4.1 Funding Scenario 19
4.2 International Patent Classification (IPC) Codes and for the Technology Areas 20
4.2.1 Life Science Research 20
4.2.2 General Research 21
4.3 Deals 21
4.4 Porter 5 (Five) Forces 26
5 Market Characteristics 28
5.1 Evolution 28
5.2 Market Segmentation 29
5.3 Market Dynamics 30
5.3.1 Drivers 30 Increase in Genetic Disorders 30 Increasing Investment and Funds 31 Technological Advancements in Genome Editing 31
5.3.2 Restraints 31 Ethical Concerns Associated to Genetic Editing 31 High Cost of Genome Engineering Technologies 32
5.3.3 Opportunities 32 Market Expansion Opportunities in Emerging Nations 32 Growing Collaboration for Genome Engineering Technologies 32
5.3.4 DRO – Impact Analysis 33
5.4 Key Stakeholders 34
6 Technology Types: Market Size and Analysis 35
6.1 Overview 35
6.2 CRISPR/Clustered Regularly Interspaced Short Palindromic Repeats 36
6.3 TALEN/Transcription Activator-Like Effector Nuclease 39
6.4 ZFN/Zinc-Finger Nucleases 40
6.5 Others 41
7 Application Types: Market Size and Analysis 43
7.1 Overview 43
7.2 Cell Line Engineering 44
7.3 Genetic Engineering 45
7.4 Others 48
8 End Users: Market Size and Analysis 50
8.1 Overview 50
8.2 Research Institutes 50
8.3 Biotechnology and Pharmaceutical Companies 51
8.4 Contract Research Organizations 52
9 Regions: Market Size and Analysis 53
9.1 Overview 53
9.2 North America 54
9.2.1 Overview 54
9.3 Europe 55
9.3.1 Overview 55
9.4 Asia Pacific 56
9.4.1 Overview 56
9.5 Rest of the World 57
9.5.1 Overview 57
10 Competitive Landscape 59
11 Vendors Profile 64
11.1 ThermoFisher Scientific, Inc. 64
11.1.1 Overview 64
11.1.2 Business Units 66
11.1.3 Geographic Presence 67
11.1.4 Business Focus 68
11.1.5 SWOT Analysis 68
11.1.6 Business Strategy 69
11.2 GenScript Corp. 70
11.2.1 Overview 70
11.2.2 Business Units 71
11.2.3 Geographic Presence 72
11.2.4 Business Focus 73
11.2.5 SWOT Analysis 73
11.2.6 Business Strategies 74
11.3.1 Overview 74
11.3.2 Business Focus 76
11.3.3 SWOT Analysis 77
11.3.4 Business Strategies 77
11.4 Lonza Group 78
11.4.1 Overview 78
11.4.2 Business Units 79
11.4.3 Geographic Presence 80
11.4.4 Business Focus 81
11.4.5 SWOT Analysis 81
11.4.6 Business Strategies 82
11.5 Horizon Discovery Group plc 82
11.5.1 Overview 82
11.5.2 Business Units 85
11.5.3 Geographic Presence 86
11.5.4 Business Focus 87
11.5.5 SWOT Analysis 87
11.5.6 Business Strategies 88
12 Companies to Watch for 89
12.1 Merck KGaA 89
12.1.1 Overview 89
12.2 Transposagen Biopharmaceuticals 90
12.2.1 Overview 90
12.3 CRISPR Therapeutics 91
12.3.1 Overview 91
12.4 Editas Medicine 92
12.4.1 Overview 92
12.5 Integrated DNA Technologies 93
12.5.1 Overview 93
12.6 New England Biolabs 94
12.6.1 Overview 94
12.7 Origene Technologies, Inc. 95
12.7.1 Overview 95
Annexure 97
 Acronyms 97

Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
ThermoFisher Scientific
GenScript Corp.
Sangamo Therapeutics
Lonza Group
Horizon Discovery Group plc
Merck KGaA
Transposagen Biopharmaceutical
CRISPR Therapeutics
Editas Medicine
Integrated DNA Technologies
New England Biolabs
Origene Technologies, Inc.
Please enter your personal details below
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports